Literature DB >> 20697110

A case of neurosarcoidosis successfully treated with rituximab.

Roberto Bomprezzi1, Sandipan Pati, Chakorn Chansakul, Timothy Vollmer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20697110     DOI： 10.1212/WNL.0b013e3181ec7ff9

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  23 in total

Review 1.  Immune mediated diseases and immune modulation in the neurocritical care unit.

Authors:  Gloria von Geldern; Thomas McPharlin; Kyra Becker
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  Age-associated B Cells Appear in Patients with Granulomatous Lung Diseases.

Authors:  Swati Phalke; Katja Aviszus; Kira Rubtsova; Anatoly Rubtsov; Briana Barkes; Linda Powers; Brenda Warner; James L Crooks; John W Kappler; Evans R Fernández-Pérez; Lisa A Maier; Nabeel Hamzeh; Philippa Marrack
Journal:  Am J Respir Crit Care Med       Date:  2020-10-01       Impact factor: 21.405

Review 3.  Update on Treatment in Cardiac Sarcoidosis.

Authors:  Laura Young; Brett W Sperry; Rory Hachamovitch
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-06

4.  Rituximab in the treatment of refractory pulmonary sarcoidosis.

Authors:  Nadera J Sweiss; Elyse E Lower; Mehdi Mirsaeidi; Steven Dudek; Joe G N Garcia; David Perkins; Patricia W Finn; Robert P Baughman
Journal:  Eur Respir J       Date:  2014-01-31       Impact factor: 16.671

Review 5.  Treatment of Sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

Review 6.  Targeting CD4(+) T cells for the treatment of sarcoidosis: a promising strategy?

Authors:  Lindsay J Celada; Wonder P Drake
Journal:  Immunotherapy       Date:  2015       Impact factor: 4.196

Review 7.  Extrapulmonary manifestations of sarcoidosis.

Authors:  Deepak A Rao; Paul F Dellaripa
Journal:  Rheum Dis Clin North Am       Date:  2013-03-13       Impact factor: 2.670

8.  Infliximab for the treatment of CNS sarcoidosis: A multi-institutional series.

Authors:  Jeffrey M Gelfand; Michael J Bradshaw; Barney J Stern; David B Clifford; Yunxia Wang; Tracey A Cho; Laura L Koth; Stephen L Hauser; Jason Dierkhising; NgocHanh Vu; Subramaniam Sriram; Harold Moses; Francesca Bagnato; Jeffrey A Kaufmann; Deidre J Ammah; Tsion H Yohannes; Mark J Hamblin; Nagagopal Venna; Ari J Green; Siddharama Pawate
Journal:  Neurology       Date:  2017-10-13       Impact factor: 9.910

9.  Treatment of Sarcoidosis in US Rheumatology Practices: Data From the American College of Rheumatology's Rheumatology Informatics System for Effectiveness (RISE) Registry.

Authors:  Nevin Hammam; Michael Evans; Esi Morgan; Andreas Reimold; Christine Anastasiou; Julia L Kay; Jinoos Yazdany; Gabriela Schmajuk
Journal:  Arthritis Care Res (Hoboken)       Date:  2022-01-28       Impact factor: 4.794

10.  Rituximab for refractory granulomatous eye disease.

Authors:  Elyse E Lower; Robert P Baughman; Adam H Kaufman
Journal:  Clin Ophthalmol       Date:  2012-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.